Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun 11;3(6):1892-1908.
doi: 10.3390/ph3061892.

A Review of Topical Diclofenac Use in Musculoskeletal Disease

Bindu Nair  1 , Regina Taylor-Gjevre  2
Affiliations
Review

A Review of Topical Diclofenac Use in Musculoskeletal Disease

Bindu Nair et al. Pharmaceuticals (Basel). .

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed medications for the treatment of musculoskeletal disorders. Osteoarthritis is the most common form of arthritis in humans and its prevalence rises with age. Oral NSAIDs have potential associated toxicities that must be monitored for and can limit the use of these drugs in certain populations including people of older age. Topical NSAIDs are now being recognized as an option for the treatment strategy of osteoarthritis. We review the efficacy and safety of one of the most common topical NSAIDS, topical diclofenac, for the treatment of osteoarthritis.

Keywords: NSAIDs; diclofenac; musculoskeletal; osteoarthritis.

PubMed Disclaimer

References

    1. Gabriel S.E., Matteson E.L. Economic and quality-of-life impact of NSAIDs in rheumatoid arthritis: A conceptual framework and selected literature review. Pharmacoeconomics. 1995;8(6):479–490. doi: 10.2165/00019053-199508060-00004. - DOI - PubMed
    1. Zochling J., Bohl-Bühler M.H.J., Baraliakos X., Feldtkeller E., Braun J. Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis—A population-based survey. Clin. Rheumatol. 2006;25(6):794–800. doi: 10.1007/s10067-005-0132-y. - DOI - PubMed
    1. Hochberg M.C. COX-2 selective inhibitors in the treatment of arthritis: A rheumatologist perspective. Curr. Top. Med. Chem. 2005;5(5):443–448. - PubMed
    1. Brooks P.M. Impact of osteoarthritis on individuals and society: How much disability? Social consequences and health economic implications. Curr. Opin. Rheumatol. 2002;14(5):573–577. doi: 10.1097/00002281-200209000-00017. - DOI - PubMed
    1. Hochberg M. Osteoarthritis. In: Silman A., Hochberg M, editors. Epidemiology of the Rheumatic Diseases. Oxford University Press; Oxford, UK: 2001. pp. 206–229.

LinkOut - more resources